To switch or not to switch —first Germany-wide study from the perspective of pharmacists in the European environment

ConclusionPharmacists strongly welcome further switches. This leads to high acceptance rates, especially for a switch of desloratadine, as this was the most named active ingredient possible for a switch within the survey.Impact of findings on practice statementsThe outcome of this survey can support pharmaceutical companies in decision-making about which active substances they should submit a switch application for. Additionally, this helps fulfil patient needs, because pharmacists know best what is beneficial for patient self-care. In addition, all other actors involved in this process can see what is required and can rethink their position regarding further switches.
Source: Journal of Public Health - Category: Health Management Source Type: research